Glucagon like peptide 1 (GLP 1) receptor agonists are incretin analogues that promote glucose mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP 1 receptor agonists and GLP 1 and glucose dependent insulinotropic Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide GLP 1 C Peptide Research Grade Lyophilized Powder BleauGenics GIP mediates the incretin effect and glucose tolerance by dual actions on cells and cells Science Advances GLP1 GIP receptor co agonists: a promising evolution in the treatment of type 2 diabetes Acta Diabetologica Springer Nature Link The Influence of Glucagon like Peptide 1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition